• Aucun résultat trouvé

MODULE FOR ASSESSING AND STRENGTHENING THE QUALITY OF VIRAL LOAD TESTING DATA WITHIN HIV PROGRAMMES AND PATIENT MONITORING SYSTEMS

N/A
N/A
Protected

Academic year: 2022

Partager "MODULE FOR ASSESSING AND STRENGTHENING THE QUALITY OF VIRAL LOAD TESTING DATA WITHIN HIV PROGRAMMES AND PATIENT MONITORING SYSTEMS"

Copied!
4
0
0

Texte intégral

(1)

HIV STRATEGIC INFORMATION FOR IMPACT

SEPTEMBER 2020

MODULE FOR ASSESSING AND STRENGTHENING THE QUALITY OF VIRAL LOAD TESTING DATA WITHIN HIV PROGRAMMES AND PATIENT MONITORING SYSTEMS

WEB ANNEX B: MAP OF PATIENT, VIRAL LOAD SAMPLE AND DOCUMENTATION FLOW

IMPLEMENT ATION TOOL

(2)

Web Annex B: Map of patient, viral load sample and documentation flow

1

In tr oduc tor y s cr ip t f or d at a a nd s er vic e m ap pi ng Th ank y ou f or h av in g us a t y ou r f ac ili ty t od ay . W e w ou ld l ik e t o lo ca te an d fi x an y da ta d ef ec ts o r b ot tle ne ck s w ith in t he d at a w or kfl ow t o i m pr ov e t he q ua lit y o f in fo rm at io n g at he re d i n r ea l t im e an d m ov in g f or w ar d. W e w ou ld l ik e t o h el p t o st reng th en a nd s tre am lin e t he p ro ce ss for v al id at ing pa tie nt h ea lth in for m at ion . To da y, w e ar e i nt er es te d i n le ar ni ng a bo ut t he d at a an d s er vi ce q ua lit y c ha lle ng es an d s uc ce ss es a t y ou r s ite . T he se g ui di ng q ue st io ns an d t he s ite v is it w ill b e an op po rt un ity t o d el ve d ee p i nt o t he c ha lle ng es , s uc ce ss es , b es t p rac tic es an d in no va tio n i n t he h ea lth i nf or m at io n s ys te m s h er e a t y ou r f ac ili ty . T o b eg in , w e w ou ld li ke y ou t o w al k u s t hr ou gh t he p ro ce ss o f o rd er in g a v ir al l oa d te st f or a p at ie nt . W he re d oe s t he p at ie nt g o f or s am pl e c ol le ct io n, w ha t ha pp en s i f a p at ie nt d oe s n ot g et a s am pl e d ra w n? W ha t h ap pe ns w he n vi ra l l oa d te st r es ul ts a re n ot r ec ei ve d? I s t he re a m ec ha ni sm t o f ol lo w u p w it h t he l ab or at or y o n te st s t ha t h av e o rd er ed b ut n o r es ul ts r ec ei ve d? A re t he re a ny b ot tl en ec ks i n t he p ro ce ss a nd , i f s o, w he re a re t he y? In st ru ct io n: s ke tc h a m ap o f s er vi ce d el iv er y fl ow b as ed o n t he r es po ns es t o t he qu es tio ns h ig hl ig ht ed a bo ve .

N am e o f i nt er vie w ee Fa cili ty c od e

WEB ANNEX B MAP OF PATIENT, VIRAL LOAD SAMPLE AND DOCUMENTATION FLOW

IN ST RU CT IO NS : S KE TC H A R OU GH M AP A ND M AK E N OT ES O F S PE CI FIC B ES T P RA CT IC ES O R P OT EN TI AL I M PR OV EM EN TS F OR E FF IC IE NC Y I N D AT A F LO W

Guiding questions Sketch flow • Is viral load testing performed routinely or targeted at specific populations? • Are any prompts or tools used to remind service providers to order a viral load test for eligible patients? • What tools are used to order a viral load test and who completes them? • How often are viral load samples picked up for transport to the laboratory? Is the schedule for pick-up followed? Reasons for deviations? • How are results transmitted from the lab to the antiretroviral therapy clinic? • What tools are used to record viral load test results • Are any tools used to support the follow-up of patients with elevated viral load? • How are the returned results entered into patient files and by whom? • How are viral load results provided to patients? • What is the process of updating registers after patient visits? • Who enters the data in registers or electronic medical records (if relevant) • Are any tools used to monitor sample collection kits and blood draw–related commodities?

N am e o f fa ci lit y

(3)

Web Annex B: Map of patient, viral load sample and documentation flow

2

List any best practices in viral load patient, sample and documentation flow 1. 2. Provide any comments or recommendations to improve efficiencies in patient, sample and documentation flow 1. 2. List 3–5 critical challenges impacting viral load monitoring and scale-up in your facility 1. 2. 3. 4. 5. Provide any comments, best practices or recommendations for strengthening viral load monitoring and scale-up that could be applicable to other settings 1. 2. 3. 4. 5.

(4)

For more information, contact:

World Health Organization Department of HIV/AIDS 20, avenue Appia 1211 Geneva 27 Switzerland

E-mail: hiv-aids@who.int www.who.int/hiv

ISBN 978-92-4-001040-6 (electronic version)

© World Health Organization 2020. Some rights reserved.

This work is available under the CC BY-NC-SA 3.0 IGO licence.

Références

Documents relatifs

The second step involves verifying and recreating key indicators (this should include the number of people currently receiving and newly initiating ART) designated by the Ministry

(Note: the specific site management team is expected to revisit the viral load data quality improvement plan to monitor progress and make necessary adjustments) Name of facility Date

• If viral load testing is not routinely available, CD4 count and clinical monitoring should be used to diagnose treatment failure, with targeted viral load testing to confirm

Only ministry of health staff or partners the ministry authorizes and engages in the data quality assurance activity will have access to the information produced by this

Data quality (DQ) assurance activity: used as an umbrella term to refer to the range of DQ activities recommended in this module, including routine DQ assessment, DQ monitoring

Indicator or monitoring areaSource(s)MethodsResponseComments Identification of stable patients with suppressed VL (<1000 copies/mL)VL testing lab database (VL sample

An M&E system of a national HTC programme requires the following data collection systems. A national inventory of HTC sites which contains basic information about all

The main distinctive feature of the specification transition system in [1] is its labels. They record not only events, like in the operational semantics, but also guards and